MedPath

TO STUDY IF THE USE OF ADENOSINE IN CONGENITAL HEART SURGERY HAS A PROTECTIVE EFFECT OVER THE HEART FUNCTIO

Not Applicable
Conditions
Health Condition 1: I52- Other heart disorders in diseasesclassified elsewhereHealth Condition 2: null- Patients of pediatric age group with congenital cardiac defects weighing less than 20 kgs
Registration Number
CTRI/2018/08/015385
Lead Sponsor
DirectorAIIMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients below 20 kgs of weight undergoing elective repair of complex congenital heart defects with aortic cross clamp times of greater than 45 minutes will be recruited in this study

Exclusion Criteria

1.Patients with isolated ASD,isolated pulmonary stenosis or patients with Bi-directional Cavo-pulmonary shunt undergoing Fontan completion.

2.Patients with chromosomal defects

3.Airway and parenchymal disease

4.Immunodeficiency or blood disorders

5.Emergency surgery

6.Parents/guardians not willing to given consent to participate in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the Cardiac Index in these groups in the post operative period <br/ ><br> <br/ ><br>To assess and compare the presence of arrhythmias in the post-operative ICU period in these groupsTimepoint: During the period of admission at the hospital
Secondary Outcome Measures
NameTimeMethod
1. To compare the duration of ICU stay in these groups <br/ ><br>2.To assess and compare the surrogates of myocardial protection in the form of <br/ ><br> A.Cardiac enzyme release <br/ ><br> B.Decreased urine output <br/ ><br> C.use of inotropes in the post-operative periodTimepoint: During the period of admission at the hospital
© Copyright 2025. All Rights Reserved by MedPath